Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications
Open Access
- 23 June 2009
- journal article
- research article
- Published by Wiley in Protein Science
- Vol. 18 (7) , 1425-1438
- https://doi.org/10.1002/pro.156
Abstract
The aim of this study was to characterize the conformational neutralizing epitopes of the major capsid protein of human papillomavirus type 31. Analysis of the epitopes was performed by competitive epitope mapping using 15 anti‐HPV31 and by reactivity analysis using a HPV31 mutant with an insertion of a seven‐amino acid motif within the FG loop of the capsid protein. Fine mapping of neutralizing conformational epitopes on HPV L1 was analyzed by a new approach using a system displaying a combinatorial library of constrained peptides exposed on E. coli flagella. The findings demonstrate that the HPV31 FG loop is dense in neutralizing epitopes and suggest that HPV31 MAbs bind to overlapping but distinct epitopes on the central part of the FG loop, in agreement with the exposure of the FG loop on the surface of HPV VLPs, and thus confirming that neutralizing antibodies are mainly located on the tip of capsomeres. In addition, we identified a crossreacting and partially crossneutralizing conformational epitope on the relatively well conserved N‐terminal part of the FG loop. Moreover, our findings support the hypothesis that there is no correlation between neutralization and the ability of MAbs to inhibit VLP binding to heparan sulfate, and confirm that the blocking of virus attachment to the extracellular matrix is an important mechanism of neutralization.Keywords
Funding Information
- Ligue Contre le Cancer (Comités départementaux d'Indre et Loire et de l'Indre), Vaincre la Mucoviscidose
- Ministère de l'Enseignement Supérieur et de la Recherche
This publication has 92 references indexed in Scilit:
- Binding of human papillomavirus type 16 to heparan sulfate is inhibited by mucosal antibodies from patients with low-grade squamous intraepithelial lesions but not from cervical cancer patientsFEMS Immunology & Medical Microbiology, 2008
- Antibodies against viruses: passive and active immunizationCurrent Opinion in Immunology, 2008
- Detection of Human Papillomavirus Type 31-Neutralizing Antibodies from Naturally Infected Patients by an Assay Based on Intracellular Assembly of Luciferase-Expressing PseudovirionsClinical and Vaccine Immunology, 2008
- Inhibition of Transfer to Secondary Receptors by Heparan Sulfate-Binding Drug or Antibody Induces Noninfectious Uptake of Human PapillomavirusJournal of Virology, 2007
- Human Papillomavirus Type 31 Uses a Caveolin 1- and Dynamin 2-Mediated Entry Pathway for Infection of Human KeratinocytesJournal of Virology, 2007
- Neutralization of Human Papillomavirus with Monoclonal Antibodies Reveals Different Mechanisms of InhibitionJournal of Virology, 2007
- Structure-Based Identification of a Major Neutralizing Site in an Adenovirus HexonJournal of Virology, 2007
- Keratinocyte-Secreted Laminin 5 Can Function as a Transient Receptor for Human Papillomaviruses by Binding Virions and Transferring Them to Adjacent CellsJournal of Virology, 2006
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Conserved Features in Papillomavirus and Polyomavirus CapsidsJournal of Molecular Biology, 1996